Finance

Lists
GYRE:NASDAQ
Gyre Therapeutics Inc
7,42ย US$
-0,14%
(-0,010) 1D
22 แƒกแƒ”แƒฅ, 12:07:31 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GYRE...
Open
7,40ย US$
High
7,61ย US$
Low
7,26ย US$
Mkt. cap
786,72ย แƒ›แƒšแƒœ.
Avg. vol.
120,06ย แƒแƒ—.
Volume
82,08ย แƒแƒ—.
52-wk high
9,42ย US$
52-wk low
5,44ย US$
EPS
-0,20ย US$
Beta
2,20
Shares outstanding
106,03ย แƒ›แƒšแƒœ.
No. of employees
625
Open
7,40ย US$
High
7,61ย US$
Low
7,26ย US$
Mkt. cap
786,72ย แƒ›แƒšแƒœ.
Avg. vol.
120,06ย แƒแƒ—.
Volume
82,08ย แƒแƒ—.
52-wk high
9,42ย US$
52-wk low
5,44ย US$
EPS
-0,20ย US$
Beta
2,20
Shares outstanding
106,03ย แƒ›แƒšแƒœ.
No. of employees
625
News stories
From web sources and news partners
AD HOC NEWS
AD HOC NEWS
·
1 แƒ“แƒฆแƒ˜แƒก แƒฌแƒ˜แƒœ
Gyre Therapeutics stock posts double digit 12 month gain as investors watch pipeline progress
About Gyre Therapeutics Inc
CEO-
Employees625
Founded1997
Headquartersแƒฃแƒ˜แƒœแƒกแƒขแƒแƒœ-แƒกแƒแƒšแƒ”แƒ›แƒ˜, แƒฉแƒ แƒ“แƒ˜แƒšแƒแƒ”แƒ—แƒ˜ แƒ™แƒแƒ แƒแƒšแƒ˜แƒœแƒ, แƒแƒ›แƒ”แƒ แƒ˜แƒ™แƒ˜แƒก แƒจแƒ”แƒ”แƒ แƒ—แƒ”แƒ‘แƒฃแƒšแƒ˜ แƒจแƒขแƒแƒขแƒ”แƒ‘แƒ˜
Sector-
Websitegyretx.com
Analyst ratings
Based on 2 analysts giving stock ratings to GYRE in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for GYRE in the last 3 months.
Highest
Current 7,42ย US$
20,00ย US$ (+169,56%)
Average
19,00ย US$ (+156,08%)
Lowest
18,00ย US$ (+142,60%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert LeBoyer
Noble Financial
Buy
Reiterated
20,00ย US$
+169,6%
08/10/2026
Matthew Keller
H.C. Wainwright
Buy
Reiterated
18,00ย US$
+142,6%
08/07/2026
Roger Song
Jefferies
Buy
Initiated
16,00ย US$
+115,6%
10/10/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
แƒกแƒ”แƒฅ. 2025
แƒ“แƒ”แƒ™. 2025
แƒ›แƒแƒ . 2026
แƒ˜แƒ•แƒœ. 2026
Revenue
30,56ย แƒ›แƒšแƒœ.
37,20ย แƒ›แƒšแƒœ.
24,43ย แƒ›แƒšแƒœ.
29,10ย แƒ›แƒšแƒœ.
Cost of goods sold
1,63ย แƒ›แƒšแƒœ.
1,74ย แƒ›แƒšแƒœ.
1,23ย แƒ›แƒšแƒœ.
2,21ย แƒ›แƒšแƒœ.
Cost of revenue
1,63ย แƒ›แƒšแƒœ.
1,74ย แƒ›แƒšแƒœ.
1,23ย แƒ›แƒšแƒœ.
2,21ย แƒ›แƒšแƒœ.
Research and development expenses
2,36ย แƒ›แƒšแƒœ.
4,82ย แƒ›แƒšแƒœ.
11,48ย แƒ›แƒšแƒœ.
19,14ย แƒ›แƒšแƒœ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,65ย แƒ›แƒšแƒœ.
30,52ย แƒ›แƒšแƒœ.
24,31ย แƒ›แƒšแƒœ.
21,62ย แƒ›แƒšแƒœ.
Operating expense
22,01ย แƒ›แƒšแƒœ.
35,33ย แƒ›แƒšแƒœ.
35,79ย แƒ›แƒšแƒœ.
40,76ย แƒ›แƒšแƒœ.
Total operating expenses
23,64ย แƒ›แƒšแƒœ.
37,08ย แƒ›แƒšแƒœ.
37,02ย แƒ›แƒšแƒœ.
42,97ย แƒ›แƒšแƒœ.
Operating income
6,93ย แƒ›แƒšแƒœ.
120,00ย แƒแƒ—.
-12,59ย แƒ›แƒšแƒœ.
-13,86ย แƒ›แƒšแƒœ.
Other non operating income
604,00ย แƒแƒ—.
-2,31ย แƒ›แƒšแƒœ.
244,00ย แƒแƒ—.
-811,00ย แƒแƒ—.
EBT including unusual items
7,63ย แƒ›แƒšแƒœ.
-66,00ย แƒแƒ—.
-18,03ย แƒ›แƒšแƒœ.
-14,43ย แƒ›แƒšแƒœ.
EBT excluding unusual items
7,63ย แƒ›แƒšแƒœ.
-864,00ย แƒแƒ—.
-11,65ย แƒ›แƒšแƒœ.
-13,93ย แƒ›แƒšแƒœ.
Income tax expense
1,69ย แƒ›แƒšแƒœ.
1,30ย แƒ›แƒšแƒœ.
549,00ย แƒแƒ—.
-164,00ย แƒแƒ—.
Effective tax rate
22,19%
-1ย 969,70%
-3,04%
1,14%
Other operating expenses
-
-
-
-
Net income
3,61ย แƒ›แƒšแƒœ.
-1,72ย แƒ›แƒšแƒœ.
-10,30ย แƒ›แƒšแƒœ.
-10,60ย แƒ›แƒšแƒœ.
Net profit margin
11,81%
-4,63%
-42,16%
-36,44%
Earnings per share
0,03
0,05
-
-
Interest and investment income
100,00ย แƒแƒ—.
1,35ย แƒ›แƒšแƒœ.
743,00ย แƒแƒ—.
740,00ย แƒแƒ—.
Interest expense
-
-
-
-
Net interest expenses
100,00ย แƒแƒ—.
1,35ย แƒ›แƒšแƒœ.
743,00ย แƒแƒ—.
740,00ย แƒแƒ—.
Depreciation and amortization charges
-
-
-
-
EBITDA
7,58ย แƒ›แƒšแƒœ.
815,00ย แƒแƒ—.
-11,92ย แƒ›แƒšแƒœ.
-12,38ย แƒ›แƒšแƒœ.
Gain or loss from assets sale
1,00ย แƒแƒ—.
2,00ย แƒแƒ—.
16,00ย แƒแƒ—.
2,00ย แƒแƒ—.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google แƒแƒžแƒ”แƒ‘แƒ˜